Risedronate sodium

Risedronate sodium

Products
Risedronate sodium
Risedronate sodium

Information

Therapeutic Area: Musculo-skeletal systemEU DMF availableUS DMF no. 20384 availableJapanese DMF availableCEP available Indication: Risedronate sodium is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism.
Main Categories
APIs (Active Pharmaceutical Ingredients)
All Categories
APIs (Active Pharmaceutical Ingredients)
Distribution areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
Poland
Polpharma SAPolpharma Group is a high quality European pharma manufacturer and a reputable business partner for companies worldwide at every stage of product development, manufacturing & commercialization (FDF, API, CDMO, CMO). Polpharma API is a Poland-based CDMO of APIs, and significant European API producer, delivering products to more than 65 countries on 6 continents. We run with $45-million manufacturing expansion to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities.

Log in

See all the content and easy-to-use features by logging in or registering!